Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $27.87 million. The enterprise value is -$45.68 million.
| Market Cap | 27.87M |
| Enterprise Value | -45.68M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, after market close.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 38.13 million shares outstanding. The number of shares has increased by 1.02% in one year.
| Shares Outstanding | 38.13M |
| Shares Change (YoY) | +1.02% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 3.47% |
| Owned by Institutions (%) | 64.28% |
| Float | 21.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.46 |
| Forward PS | n/a |
| PB Ratio | 0.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.68, with a Debt / Equity ratio of 0.19.
| Current Ratio | 5.68 |
| Quick Ratio | n/a |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.70% and return on invested capital (ROIC) is -60.52%.
| Return on Equity (ROE) | -51.70% |
| Return on Assets (ROA) | -37.70% |
| Return on Capital (ROIC) | -60.52% |
| Revenue Per Employee | $113,240 |
| Profits Per Employee | -$630,280 |
| Employee Count | 100 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.88% in the last 52 weeks. The beta is 0.93, so BOLT's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -48.88% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 1.02 |
| Relative Strength Index (RSI) | 41.89 |
| Average Volume (20 Days) | 119,132 |
Short Selling Information
The latest short interest is 1.85 million, so 4.85% of the outstanding shares have been sold short.
| Short Interest | 1.85M |
| Short Previous Month | 1.85M |
| Short % of Shares Out | 4.85% |
| Short % of Float | 8.63% |
| Short Ratio (days to cover) | 12.19 |
Income Statement
In the last 12 months, BOLT had revenue of $11.32 million and -$63.03 million in losses. Loss per share was -$1.66.
| Revenue | 11.32M |
| Gross Profit | 11.32M |
| Operating Income | -74.87M |
| Pretax Income | -63.03M |
| Net Income | -63.03M |
| EBITDA | -58.18M |
| EBIT | -63.03M |
| Loss Per Share | -$1.66 |
Balance Sheet
The company has $93.12 million in cash and $19.57 million in debt, giving a net cash position of $73.55 million or $1.93 per share.
| Cash & Cash Equivalents | 93.12M |
| Total Debt | 19.57M |
| Net Cash | 73.55M |
| Net Cash Per Share | $1.93 |
| Equity (Book Value) | 104.16M |
| Book Value Per Share | 2.73 |
| Working Capital | 78.33M |
Cash Flow
In the last 12 months, operating cash flow was -$62.88 million and capital expenditures -$203,000, giving a free cash flow of -$63.08 million.
| Operating Cash Flow | -62.88M |
| Capital Expenditures | -203,000 |
| Free Cash Flow | -63.08M |
| FCF Per Share | -$1.66 |
Margins
Gross margin is 100.00%, with operating and profit margins of -661.19% and -556.59%.
| Gross Margin | 100.00% |
| Operating Margin | -661.19% |
| Pretax Margin | -556.59% |
| Profit Margin | -556.59% |
| EBITDA Margin | -513.75% |
| EBIT Margin | -556.59% |
| FCF Margin | -557.05% |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.02% |
| Shareholder Yield | -1.02% |
| Earnings Yield | -226.14% |
| FCF Yield | -226.33% |
Analyst Forecast
The average price target for BOLT is $1.25, which is 71.00% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.25 |
| Price Target Difference | 71.00% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 26.49% |
| EPS Growth Forecast (5Y) | -26.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BOLT has an Altman Z-Score of -3.96 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.96 |
| Piotroski F-Score | 3 |